SEI Investments’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,097
| Closed | -$1.93M | – | 2727 |
|
|
2023
Q4 | $1.93M | Sell |
6,097
-1,442
| -19% | -$280K | ﹤0.01% | 1617 |
|
|
2023
Q3 | $1.27M | Sell |
7,539
-1,931
| -20% | -$363K | ﹤0.01% | 1802 |
|
|
2023
Q2 | $2.05M | Sell |
9,470
-285
| -3% | -$61.1K | ﹤0.01% | 1626 |
|
|
2023
Q1 | $1.77M | Buy |
9,755
+87
| +0.9% | +$16.6K | ﹤0.01% | 1672 |
|
|
2022
Q4 | $1.9M | Sell |
9,668
-2,172
| -18% | -$466K | ﹤0.01% | 1522 |
|
|
2022
Q3 | $2.66M | Buy |
11,840
+7,519
| +174% | +$1.52M | 0.01% | 1401 |
|
|
2022
Q2 | $547K | Buy |
4,321
+1,137
| +36% | +$131K | ﹤0.01% | 2064 |
|
|
2022
Q1 | $404K | Sell |
3,184
-1,572
| -33% | -$177K | ﹤0.01% | 2183 |
|
|
2021
Q4 | $623K | Buy |
4,756
+1,167
| +33% | +$151K | ﹤0.01% | 2014 |
|
|
2021
Q3 | $439K | Sell |
3,589
-67
| -2% | -$7.73K | ﹤0.01% | 2134 |
|
|
2021
Q2 | $417K | Sell |
3,656
-816
| -18% | -$95.4K | ﹤0.01% | 2184 |
|
|
2021
Q1 | $538K | Sell |
4,472
-847
| -16% | -$96K | ﹤0.01% | 1995 |
|
|
2020
Q4 | $540K | Sell |
5,319
-930
| -15% | -$86.2K | ﹤0.01% | 1946 |
|
|
2020
Q3 | $483K | Sell |
6,249
-4,260
| -41% | -$363K | ﹤0.01% | 1903 |
|
|
2020
Q2 | $1.17M | Sell |
10,509
-269
| -2% | -$23.4K | ﹤0.01% | 1493 |
|
|
2020
Q1 | $776K | Buy |
10,778
+2,209
| +26% | +$189K | ﹤0.01% | 1573 |
|
|
2019
Q4 | $646K | Buy |
+8,569
| New | +$375K | ﹤0.01% | 1829 |
|
Other funds holding KRTX
SEI Investments's KRTX Position: Q1 2024 in Review
SEI Investments sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 6,097 shares — an estimated $1.93M sold.
SEI Investments first reported a position in KRTX in Q4 2019 and held it in 17 quarters. The position peaked at $2.66M in Q3 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.
- SEI Investments reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- SEI Investments sold 6,097 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.93M.
- SEI Investments first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2019 and held it in 17 quarters.
- SEI Investments's Karuna Therapeutics, Inc. Common Stock position peaked at $2.66M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.
Based on SEI Investments's 13F filing for Q1 2024, filed 7 May 2024.